We are live on ! Find out more
CL

Chubb Ltd Portfolio holdings

AUM $29.9M
1-Year Est. Return 48.89%
This Fund
S&P 500
This Quarter Est. Return
+17.73%
1 Year Est. Return
-48.89%
3 Year Est. Return
-64.23%
5 Year Est. Return
-53.98%
10 Year Est. Return
AUM
$28.1M
AUM Growth
+$7.88M
Cap. Flow
+$4.19M
Cap. Flow %
14.88%
Top 10 Hldgs %
100%
Holding
4
New
1
Increased
1
Reduced
Closed

Top Buys

Rank Stock Value
1
SNY icon
Sanofi
SNY
+$3.06M
2
PHR icon
Phreesia
PHR
+$1.12M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 98.86%
2 Financials 1.14%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SNY icon
1
Sanofi
SNY
$105B
$26.2M 93.05%
513,060
+63,060
+14% +$3.06M
PHR icon
2
Phreesia
PHR
$660M
$1.22M 4.33%
+43,125
New +$1.12M
PTCT icon
3
PTC Therapeutics
PTCT
$6.47B
$415K 1.47%
8,180
NEWT icon
4
NewtekOne
NEWT
$432M
$320K 1.14%
17,555

Similar funds

Chubb Ltd's Q2 2020 Portfolio in Review

As of Q2 2020, Chubb Ltd held 4 positions worth $28.1M, up 39% from $20.3M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Chubb Ltd deployed $4.19M of net new capital in Q2 2020, opening 1 new position and adding to 1 existing holding. Its largest new stake was Phreesia: 43,125 shares worth $1.22M.

By sector, the portfolio is most concentrated in Healthcare at 99% of assets, up from 99% a quarter earlier, followed by Financials.

  • Chubb Ltd's largest Q2 2020 buy was Phreesia: 43,125 shares worth $1.22M.
  • Chubb Ltd added most to Sanofi in Q2 2020, an estimated $3.06M increase.
  • Chubb Ltd's ten largest holdings make up 100% of its $28.1M portfolio in Q2 2020.
  • Chubb Ltd opened 1 new position and closed 0 in Q2 2020.
  • Chubb Ltd's portfolio value rose 39% quarter-over-quarter to $28.1M.

Based on Chubb Ltd's 13F filing for Q2 2020, filed 11 Aug 2020.